Two Mission executives named PharmaVOICE 100 most inspiring people and a third receives prestigious Red Jacket Award

SAN ANTONIO, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Mission Pharmacal Company (“Mission”) announced today that its President of Commercial Operations, Terry Herring, and Senior Vice President of Corporate Marketing, Natalie Sirjuesingh, were honored in the 2017 July/August issue of PharmaVOICE magazine for their contributions to the life sciences industry. Alamo Pharma Services (“Alamo”) Chief Operating Officer Peter Marchesini was also honored in the issue for his work with Alamo, a member of the Mission Family of Companies.

Pictured are Mission Family of Company executives who have been recognized by PharmaVOICE magazine over the past three years. Honorees for 2017 include Terry Herring, Mission Pharmacal President of Commercial Operations; Natalie Sirjuesingh, Mission Pharmacal Senior Vice President of Corporate Marketing; and Peter Marchesini, Chief Operating Officer of Alamo Pharma Services, Inc.

Sirjuesingh and Marchesini were named to the 2017 PharmaVOICE 100 annual list of the 100 most inspiring people working in the life sciences industry. The PharmaVOICE 100 honor recognizes leaders in the industry who have inspired others through their innovative and strategic contributions and effective leadership style. According to PharmaVOICE, these elite individuals are the driving force in the life sciences industry. Herring received the Red Jacket Award, a prestigious annual distinction created by PharmaVOICE to honor individuals who are “the best of the best,” those who have raised the bar in terms of what being an inspired leader means. To even be nominated for this distinction, individuals must have been recipients of the PharmaVOICE 100 recognition multiple times.

Having three recipients this year brings the Mission Family of Companies’ total to five executives honored in the past three years. The previous two recipients were:

  • Neill “Gobie” Walsdorf, Jr., Mission President and Chief Executive Officer, named to PharmaVOICE 100 in 2015

  • Juan Mantelle, Chief Operating Officer of ProSolus, Inc., a part of the Mission Family of Companies, named to PharmaVOICE 100 in 2016

Herring, named to PharmaVOICE 100 in 2007 and 2008, received the Red Jacket Award this year for his proven track record of being a visionary and his aptitude for devising innovative commercial solutions, attributes that allow him to bring tremendous value to the marketplace. In particular, Herring applied his strategic thinking, immense industry knowledge, and effective leadership style to help implement an innovative business strategy that led to the Mission Family of Companies, a collection of wholly-owned subsidiaries that have allowed Mission to streamline and expand its offerings.

As a leader, Herring inspires and challenges others to think differently and always makes a point to engage with his employees, inspiring them to succeed. Committed to giving back to the community, Herring serves on the board of directors for Bridging the Gap Africa, a nonprofit organization that builds footbridges across rivers in Kenya to provide locals with safe crossings and access to healthcare, education and economic opportunity.

First-time recipient of the honor, Sirjuesingh was named to PharmaVOICE 100 for being an extraordinary marketing executive and inspiring leader. During the transformation of the Mission Family of Companies, Sirjuesingh championed positive change on the marketing side. For example, she helped strategically link Mission with the March of Dimes Foundation®, the leading nonprofit organization for pregnancy and baby health, and continues to maintain this relationship. The outcome has been a fruitful, now eight-year relationship for both organizations.

Those who work with Sirjuesingh praise her for being a mentor and an excellent role model to those around her. Her encouragement of new ideas, compassionate demeanor, and ability to produce results, no matter the obstacle, make her a leader people want to follow.

Marchesini utilizes his more than 25 years of pharmaceutical industry experience to lead Alamo in offering pharmaceutical and biotech company clients an innovative and thoughtful approach to deploying high impact sales teams. The company’s turnkey solutions include service offerings ranging from recruiting and hiring to training and ongoing operational support of sales teams. Marchesini’s expertise is further enhanced by his role on the faculty at Rutgers Business School, where he co-teaches the course Managing the Pharmaceutical Sales Force, a core course of the Pharmaceutical MBA program.

“Mission has always been committed to fulfilling customer and patient needs. That’s why we made the decision to expand our product and service offerings and form the Mission Family of Companies,” says Walsdorf, Jr. “Such a task required a true team effort, and Terry Herring, Natalie Sirjuesingh, and Pete Marchesini have all been key drivers. Beyond Terry’s persistent vision, Natalie’s clear focus, and Pete’s drive to make Alamo a success, each are respected leaders. Terry inspires and builds up team members to always think and act in an innovative manner, Natalie’s authentic compassion is contagious, and Pete’s leadership style has proven tremendously effective.”

More than twelve years ago, PharmaVOICE magazine established the PharmaVOICE 100. Selected from thousands of nominations, recipients are identified based on substantive accounts that illustrate how they have inspired or motivated their colleagues, peers, and competitors; have positively impacted their own organizations; and have contributed to their communities and other philanthropic causes.

In 2014, PharmaVOICE magazine created the Red Jacket Award, their version of a “hall of fame” for PharmaVOICE 100 recipients who had been named to PharmaVOICE 100 multiple times. Recipients are individuals who challenge us to think, act and lead differently. True transformers of the life-sciences industry, they create new opportunities, have a persistence of vision and are inspired leaders.

To view the complete PharmaVOICE Red Jacket Award profile for Herring, and/or the PharmaVOICE 100 profiles for Sirjuesingh and Marchesini, please visit the July/August 2017 online digital edition at

About Mission Pharmacal Company

Mission Pharmacal Company is a privately held pharmaceutical company based in San Antonio, Texas. For more than seven decades, the company has been improving the lives of people through every stage of life by identifying unmet healthcare needs and delivering innovative, high-quality prescription, over-the-counter, and dietary supplement products to meet these needs using only the purest ingredients and FDA-approved methods of manufacturing. Mission is recognized as a pioneer and leader in the therapeutic areas of women’s health and urology and also offers leading products through its pediatric, dermatology, primary care, and long-term care service lines. With the shared objective of improving the health of all moms and babies, Mission is proud to support the March of Dimes Foundation®, the leading nonprofit organization for pregnancy and baby health.

Using an innovative business model, Mission created the Mission Family of Companies, a collection of wholly-owned subsidiaries including BioComp Pharma, Inc., a generic drug marketer; Alamo Pharma Services, Inc., a specialized contract sales organization; ProSolus, Inc., a transdermal drug developer and manufacturer; Espada Dermatology, Inc., a prescription and esthetic dermatology company; as well as BexR Logistix, LLC and their subsidiary company, EPIC Fulfillment, Inc., the logistics and fulfillment arms of the organization. Each company functions independently while their product and service offerings can be linked together to offer customizable solutions to a wide array of forward-thinking pharmaceutical and biotech companies. To learn more, please visit

# # #


A photo accompanying this announcement is available at


A photo accompanying this announcement is available at

Drew Deeter Mission Pharmacal Company 215.348.3890

Source:Mission Pharmacal Company